These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24610676)

  • 1. Trends in attention deficit hyperactivity disorder drugs consumption, Israel, 2005-2012.
    Ponizovsky AM; Marom E; Fitoussi I
    Pharmacoepidemiol Drug Saf; 2014 May; 23(5):534-8. PubMed ID: 24610676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate.
    Treceño C; Martín Arias LH; Sáinz M; Salado I; García Ortega P; Velasco V; Jimeno N; Escudero A; Velasco A; Carvajal A
    Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):435-41. PubMed ID: 22253017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in attention-deficit/hyperactivity disorder drug consumption in children and adolescents in Slovenia from 2001 to 2012: a drug use study from a national perspective.
    Štuhec M; Locatelli I; Švab V
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):254-9. PubMed ID: 25803789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in consumption of opioid analgesics in Israel 2009 to 2016: An update focusing on oxycodone and fentanyl formulations.
    Ponizovsky AM; Marom E; Weizman A; Schwartzberg E
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):535-540. PubMed ID: 29488288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in consumption of psychiatric drugs in Serbia and Montenegro 2000-2004.
    Divac N; Tosevski DL; Babić D; Djurić D; Prostran M; Samardzić R
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):835-8. PubMed ID: 16958148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in opioid analgesics consumption, Israel, 2000-2008.
    Ponizovsky AM; Marom E; Zeldin A; Cherny NI
    Eur J Clin Pharmacol; 2011 Feb; 67(2):165-8. PubMed ID: 21057940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the consumption rates and regulatory barriers to the accessibility of strong opioid analgesics in Israel and St. Petersburg.
    Ponizovsky AM; Pchelintsev MV; Marom E; Zvartau EE
    Eur J Clin Pharmacol; 2012 Jan; 68(1):89-95. PubMed ID: 21792563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada.
    Tett SE; Sketris I; Cooke C; van Zanten SV; Barozzi N
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):735-43. PubMed ID: 23559528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.
    Christensen L; Sasané R; Hodgkins P; Harley C; Tetali S
    Curr Med Res Opin; 2010 Apr; 26(4):977-89. PubMed ID: 20178404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Attention deficit hyperactivity disorder: pharmacological options that are not "Ritalin"].
    Shmueli D; Gross-Tsur V
    Harefuah; 2005 Aug; 144(8):572-6, 597. PubMed ID: 16146157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do therapeutic indications of antidepressants change from one year to another?
    De las Cuevas C; Sanz E
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):309-14. PubMed ID: 15133783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulant and non-stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006-2009.
    Zetterqvist J; Asherson P; Halldner L; Långström N; Larsson H
    Acta Psychiatr Scand; 2013 Jul; 128(1):70-7. PubMed ID: 22943458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data.
    Sonuga-Barke EJ; Swanson JM; Coghill D; DeCory HH; Hatch SJ
    BMC Psychiatry; 2004 Sep; 4():28. PubMed ID: 15458569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends of outpatient prescription drug utilization in US children, 2002-2010.
    Chai G; Governale L; McMahon AW; Trinidad JP; Staffa J; Murphy D
    Pediatrics; 2012 Jul; 130(1):23-31. PubMed ID: 22711728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Benefit of the extended-release methylphenidate formulations: a comparative study in childhood].
    Favreau A; Deseille-Turlotte G; Brault F; Giraudeau B; Krier C; Barthez MA; Castelnau P
    Arch Pediatr; 2006 May; 13(5):442-8. PubMed ID: 16597499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovations and recent trends in the treatment of ADHD.
    Madaan V; Kinnan S; Daughton J; Kratochvil CJ
    Expert Rev Neurother; 2006 Sep; 6(9):1375-85. PubMed ID: 17009924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of ADHD drugs in the Nordic countries: a population-based comparison study.
    Zoëga H; Furu K; Halldórsson M; Thomsen PH; Sourander A; Martikainen JE
    Acta Psychiatr Scand; 2011 May; 123(5):360-7. PubMed ID: 20860726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of methylphenidate prescription among school-aged children in a Swiss population: increase in the number of prescriptions in the Swiss Canton of Vaud, from 2002 to 2005, and changes in patient demographics.
    Gumy C; Huissoud T; Dubois-Arber F
    J Atten Disord; 2010 Nov; 14(3):267-72. PubMed ID: 20484708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.